Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium

O Gubbay1, H O D Critchley, J M Bowen

  • 1Medical Research Council Human Reproductive Sciences Unit, University of Edinburgh, Centre for Reproductive Biology, Edinburgh EH3 9ET, United Kingdom.

Insights

Prolactin (PRL) stimulates the MAPK/ERK pathway in human endometrial cells, including glandular epithelial and stromal cells. Uterine natural killer (NK) cells are identified as novel prolactin target cells.

Area of Science:

  • Reproductive immunology
  • Endocrinology
  • Cell signaling

Background:

  • Prolactin (PRL) receptors are present in the human endometrium during the secretory phase.
  • PRL signaling involves Janus kinase 2 and STAT proteins in the endometrium.

Purpose of the Study:

  • To investigate the effect of PRL on the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway in the human endometrium.
  • To identify specific cell types within the endometrium that respond to PRL via the MAPK/ERK pathway.

Main Methods:

  • Western blot analysis of endometrial proteins after PRL stimulation.
  • Immunohistochemistry and immunofluorescence to localize ERK phosphorylation.
  • RT-PCR and Western blotting on purified uterine CD56(+) NK cells.

Main Results:

  • PRL rapidly induced tyrosine and threonine phosphorylation of ERK 1 and 2 MAPKs in human endometrial tissue.
  • PRL-induced ERK phosphorylation was observed in glandular epithelial cells and stromal cells.
  • Uterine CD56(+) natural killer (NK) cells were identified as a specific stromal cell type expressing PRL receptors and responding to PRL with ERK phosphorylation.

Conclusions:

  • PRL stimulates the MAPK/ERK pathway in multiple endometrial cell compartments.
  • Uterine CD56(+) NK cells are novel target cells for PRL in the human endometrium.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.